(LEGH) Legacy Housing - Overview
Stock: Manufactured Homes, Tiny Houses, Financing, Wholesale, Retail
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 34.2% |
| Relative Tail Risk | -11.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.64 |
| Alpha | -28.45 |
| Character TTM | |
|---|---|
| Beta | 0.457 |
| Beta Downside | 0.240 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.55% |
| CAGR/Max DD | 0.05 |
Description: LEGH Legacy Housing December 26, 2025
Legacy Housing Corp. (NASDAQ: LEGH) builds, sells, and finances manufactured homes and tiny houses, mainly in the southern United States. Its product line spans 1- to 5-bedroom units with up to 3½ baths, and the company distributes through independent retailers, company-owned stores, and directly to manufactured-home communities. In addition to wholesale financing for dealers and parks, LEGH provides retail consumer loans, inventory financing for retailers, and capital to community owners that purchase or lease its homes for rental use. The firm also develops new manufactured-home communities under the Legacy brand and has been operating since 2005 from its headquarters in Bedford, Texas.
Key operating metrics (2023) show revenue of roughly $180 million and net income of $12 million, reflecting a modest profit margin of about 6.7 %. The average selling price of a Legacy home was approximately $80 k, and inventory turnover was 4.5 ×, indicating relatively efficient stock management. The manufactured-home sector is currently driven by a chronic shortage of affordable housing and a 5 % year-over-year growth in unit deliveries, but it remains sensitive to interest-rate fluctuations-higher rates can suppress financing demand, while lower rates tend to boost both sales and loan volume.
For a deeper quantitative dive, the ValueRay platform offers granular metrics and scenario analysis on LEGH’s fundamentals.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 48.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.51 > 1.0 |
| NWC/Revenue: 78.95% < 20% (prev 48.93%; Δ 30.01% < -1%) |
| CFO/TA 0.05 > 3% & CFO 26.0m > Net Income 48.1m |
| Net Debt (-12.5m) to EBITDA (61.1m): -0.21 < 3 |
| Current Ratio: 5.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (24.4m) vs 12m ago -1.52% < -2% |
| Gross Margin: 44.48% > 18% (prev 0.51%; Δ 4396 % > 0.5%) |
| Asset Turnover: 33.45% > 50% (prev 31.40%; Δ 2.05% > 0%) |
| Interest Coverage Ratio: 1184 > 6 (EBITDA TTM 61.1m / Interest Expense TTM 50.0k) |
Altman Z'' 10.00
| A: 0.26 (Total Current Assets 172.6m - Total Current Liabilities 30.1m) / Total Assets 557.9m |
| B: 0.64 (Retained Earnings 355.0m / Total Assets 557.9m) |
| C: 0.11 (EBIT TTM 59.2m / Avg Total Assets 539.7m) |
| D: 9.77 (Book Value of Equity 355.0m / Total Liabilities 36.3m) |
| Altman-Z'' Score: 14.75 = AAA |
Beneish M -3.26
| DSRI: 0.51 (Receivables 44.2m/78.8m, Revenue 180.5m/163.7m) |
| GMI: 1.16 (GM 44.48% / 51.39%) |
| AQI: 0.85 (AQ_t 0.58 / AQ_t-1 0.69) |
| SGI: 1.10 (Revenue 180.5m / 163.7m) |
| TATA: 0.04 (NI 48.1m - CFO 26.0m) / TA 557.9m) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of LEGH shares?
Over the past week, the price has changed by +1.40%, over one month by +5.46%, over three months by -6.98% and over the past year by -20.18%.
Is LEGH a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LEGH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.7 | 22% |
| Analysts Target Price | 25.7 | 22% |
| ValueRay Target Price | 20.7 | -1.6% |
LEGH Fundamental Data Overview February 03, 2026
P/S = 2.744
P/B = 0.9495
Revenue TTM = 180.5m USD
EBIT TTM = 59.2m USD
EBITDA TTM = 61.1m USD
Long Term Debt = 142.0k USD (from longTermDebt, two quarters ago)
Short Term Debt = 432.0k USD (from shortTermDebt, last quarter)
Debt = 1.00m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -12.5m USD (from netDebt column, last quarter)
Enterprise Value = 482.7m USD (495.3m + Debt 1.00m - CCE 13.6m)
Interest Coverage Ratio = 1184 (Ebit TTM 59.2m / Interest Expense TTM 50.0k)
EV/FCF = 26.15x (Enterprise Value 482.7m / FCF TTM 18.5m)
FCF Yield = 3.82% (FCF TTM 18.5m / Enterprise Value 482.7m)
FCF Margin = 10.23% (FCF TTM 18.5m / Revenue TTM 180.5m)
Net Margin = 26.66% (Net Income TTM 48.1m / Revenue TTM 180.5m)
Gross Margin = 44.48% ((Revenue TTM 180.5m - Cost of Revenue TTM 100.2m) / Revenue TTM)
Gross Margin QoQ = 41.84% (prev 47.03%)
Tobins Q-Ratio = 0.87 (Enterprise Value 482.7m / Total Assets 557.9m)
Interest Expense / Debt = 1.30% (Interest Expense 13.0k / Debt 1.00m)
Taxrate = 15.72% (1.61m / 10.3m)
NOPAT = 49.9m (EBIT 59.2m * (1 - 15.72%))
Current Ratio = 5.74 (Total Current Assets 172.6m / Total Current Liabilities 30.1m)
Debt / Equity = 0.00 (Debt 1.00m / totalStockholderEquity, last quarter 521.6m)
Debt / EBITDA = -0.21 (Net Debt -12.5m / EBITDA 61.1m)
Debt / FCF = -0.68 (Net Debt -12.5m / FCF TTM 18.5m)
Total Stockholder Equity = 508.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.92% (Net Income 48.1m / Total Assets 557.9m)
RoE = 9.47% (Net Income TTM 48.1m / Total Stockholder Equity 508.0m)
RoCE = 11.65% (EBIT 59.2m / Capital Employed (Equity 508.0m + L.T.Debt 142.0k))
RoIC = 9.82% (NOPAT 49.9m / Invested Capital 508.1m)
WACC = 7.59% (E(495.3m)/V(496.3m) * Re(7.60%) + D(1.00m)/V(496.3m) * Rd(1.30%) * (1-Tc(0.16)))
Discount Rate = 7.60% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.07%
[DCF Debug] Terminal Value 72.16% ; FCFF base≈14.8m ; Y1≈9.73m ; Y5≈4.44m
Fair Price DCF = 4.45 (EV 93.8m - Net Debt -12.5m = Equity 106.3m / Shares 23.9m; r=7.59% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -50.44 | EPS CAGR: -45.36% | SUE: -3.09 | # QB: 0
Revenue Correlation: -62.45 | Revenue CAGR: -6.70% | SUE: -0.44 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.51 | Chg30d=-0.055 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.12 | Chg30d=-0.393 | Revisions Net=-2 | Growth EPS=+14.2% | Growth Revenue=+6.4%